ClinicalTrials.Veeva

Menu

Comparison of 6-fluoro-[18F]-L-dihydroxyphenylalanine (18F-DOPA) Positron Emission Tomography (PET) and Multiparametric Resonance Magnetic Imagery (RMI) in Initial Exploration of Glial Tumors (GLIROPA)

C

Center Eugene Marquis

Status

Completed

Conditions

Brain Neoplasms
Adult Brain Tumor

Treatments

Diagnostic Test: PET imagery

Study type

Interventional

Funder types

Other

Identifiers

NCT03525080
2017-4-52-010

Details and patient eligibility

About

For patient having a brain tumor, RMI is the standard exam for tumor characterization and determines initial surgery.

The aim of this study is to assess if PET could provide additional information that could have an impact on surgery (indication and planification)

Enrollment

16 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Suspected glial resectable tumor
  • Free and informed consent
  • Affiliated to French social security

Exclusion criteria

  • Suspected high grade glioma
  • Surgical emergency
  • Pregnant or breastfeeding woman
  • Patient deprived of their liberty or under guardianship
  • Patient not able to follow study medical monitoring for geographical, social or psychological reasons
  • Treated with carbidopa, catechol-O-methyl transferase inhibitor, haloperidol, reserpine within 2 weeks before PET imagery

Trial design

Primary purpose

Diagnostic

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

16 participants in 1 patient group

PET Arm
Experimental group
Treatment:
Diagnostic Test: PET imagery

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems